Select a community
Parkinson's
Find out more about the PatientsLikeMe
Parkinson's Community
Home > Community Treatment Reports > Rasagiline Treatment Report
What is Rasagiline?

Rasagiline is an anti-Parkinson's agent and MAO inhibitor which can enhance the activity of dopamine. It is used for initial monotherapy or as adjunct to levodopa in the treatment of idiopathic Parkinson's disease.

Side Effects

Side effects as an overall problem

Severe
10 6%
Moderate
13 8%
Mild
26 15%
None
124 72%

Most commonly reported side effects

Urinary frequency
18 33%
Anxiety
12 22%
Headaches
11 20%
Difficulty falling asleep (sleep onset insomnia)
10 19%
Nausea
8 15%
Skin rash
6 11%
  • Mild
  • Moderate
  • Severe

Dosages

Top 10 dosages based on patients currently taking Rasagiline. See all 13 dosages

  daily 0.05 mg daily 0.3 mg daily 0.5 mg daily 0.5 other daily 0.75 mg daily 1 mg daily 1.5 mg daily 2 mg daily 3 mg daily 5 mg daily 6 mg daily 1000 mg daily
  19 Number of Patients: 19 2 Number of Patients: 2 1 Number of Patients: 1 91 Number of Patients: 91 1 Number of Patients: 1 1 Number of Patients: 1 446 Number of Patients: 446 4 Number of Patients: 4 5 Number of Patients: 5 1 Number of Patients: 1 4 Number of Patients: 4 1 Number of Patients: 1 1 Number of Patients: 1  

Stop Reasons

Why Patients Stopped Taking Rasagiline (multiple reasons could be selected)
Reason # Patients Percentage of patients
Side effects too severe
42 39% Side effects too severe: 39%
Did not seem to work
39 36% Did not seem to work: 36%
Doctor's advice
27 25% Doctor's advice: 25%
Other
17 16% Other: 16%
Expense
12 11% Expense: 11%
Personal research
7 7% Personal research: 7%
Change in health plan coverage
1 1% Change in health plan coverage: 1%
Not indicated
1 1% Not indicated: 1%

See all 103 patients who’ve stopped taking Rasagiline

Currently Taking Rasagiline

0-1 month 1-3 months 3-6 months 6 months-1year 1-2 years 2 years or more

Stopped Taking Rasagiline

0-1 month 1-3 months 3-6 months 6 months-1year 1-2 years 2 years or more

Adherence, Burden & Cost See details from patient evaluations

Adherence

Taking treatment as prescribed

Always
153 88%
Usually
13 8%
Sometimes
2 1%
Never
5 3%

Burden

Difficulty being on treatment

Very
9 5%
Somewhat
14 8%
A little
20 12%
Not at all
130 75%

Cost

Paid out of pocket

$200+
11 6%
$100-199
13 8%
$50-99
15 9%
$25-49
33 19%
< $25
55 32%

See more information, including instructions, precautions, side effects, and interactions.

Report created on March 21, 2010.